Telomerase therapeutics: Telomeres recognized as a DNA damage signal

Clinical Cancer Research

Volumn 9, Issue 10 I, 2003, Pages 3521-3525

  Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

CELL DEATH; CELL IMMORTALIZATION; CELL KILLING; CELL TRANSFORMATION; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GENETIC STABILITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TANDEM REPEAT; TARGET CELL; TELOMERE; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DNA; DNA DAMAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MICROSCOPY, FLUORESCENCE; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 0141456502     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell, 100: 57-70, 2000.
2. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash. DC), 26: 2011-2015, 1994.
3. Shay, J. W., and Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer, 5: 787-791, 1997.
4. Shay, J. W. Telomerase in cancer: Diagnostic, prognostic and therapeutic implications. Cancer J. Sci. Am., 4: 26-33, 1998.
5. Bearss, D. J., Hurley, L. H., and Von Hoff, D. D. Telomere maintenance mechanisms as a target for drug development. Oncogene, 19: 6632-6641. 2000.
6. Keith, W. K., Evans, T. R. J., and Glasspool, R. M. Telomerase and cancer: time to move from a promising target to a clinical reality. J. Pathol., 195: 404-414, 2001.
7. White, L., Wright, W. E., and Shay, J. W. Telomerase inhibitors. Trends Biotech., 19: 114-120, 2001.
8. Kelland, L. R. Telomerase: biology and phase I trials. Lancet Oncol., 2: 95-102, 2001.
9. Hodes, R. Molecular targeting of cancer: telomeres as targets. Proc. Natl. Acad. Sci. USA 98: 7649-7651, 2001.
10. Shay, J. W., and Wright, W. E. Telomerase: a target for cancer therapy. Cancer Cell, 2: 257-265, 2002.
11. Kraemer, K., Fussel, S., Schimdt, U., Kotzsch, M., Schwenzer, B., Wirth, M. P., and Meye, A. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res., 9: 3794-3800, 2003.
12. Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., and de Lange, T. Mammalian telomeres end in a large duplex loop. Cell, 97: 503-514, 1999.
13. Wright, W. E., and Shay, J. W. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genes Dev., 11: 98-103, 2001.
14. Kim, S. H., Kaminker, P., and Campisi, J. Telomeres, aging and cancer: in search of a happy ending. Oncogene, 21: 503-511, 2002.
15. Zhang, X., Multani, A. S., Zhou, J-H., Shay, J. W., McConkey, D. M., Dong, L., Kim, C-S., Rosser, C. J., Pathak, S., and Benedict, W. F. Ad-RB94 produces rapid telomere erosion, chromosomal crisis and caspase dependent apoptosis in bladder cancer and immortalized human urothelial cells, but not in normal urothelial cells Cancer Res., 63: 760-765, 2003.
16. von Zglinicki, T. Oxidative stress shortens telomeres. Trends Biochem. Sci., 27: 339-344, 2002.
17. Oikawa, S., and Kawanishi, S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett., 453: 365-368, 1999.
18. Ramirez, R. D., Morales, C. P., Herbert, B. S., Rohde, J. M., Passons, C., Shay, J. W., and Wright, W. E. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev., 15: 398-403, 2001.
19. Sherr, C. J., and DePinho, R. A. Cellular senescence: mitotic clock or culture shock? Cell, 102: 407-410, 2000.
20. Drayton, S., and Peters, G. Immortalisation and transformation revisited. Curr. Opin. Genet. Dev., 12: 98-104, 2002.
21. Ronison, I. B. Tumor cell senescence in cancer treatment. Cancer Res., 63: 2705-2715.
22. Wright, W. E., and Shay, J. W. Fundamental differences in human and mouse telomere biology. Nat. Med., 6: 849-851, 2000.
23. Henson, J. D., Neumann, A. A., Yeager, T. R., and Reddel, R. R. Alternative lengthening of telomeres in mammalian cells. Oncogene, 21: 598-610, 2002.
24. Karlseder, J., Smogorzewska, A., and de Lange, T. Senescence induced by altered telomere state, not telomere loss. Science (Wash. DC), 295: 2446-2449, 2002.
25. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., and Shay, J. W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med., 1: 249-257, 1995.
26. Seger, Y. R., Garcia-Cao, M., Piccinin, S., Cunsolo, C. L., Doglioni, C., Blasco, M. A., Hannon, G. J., and Maestro, R. Transformation of normal human cells in the absence of telomerase activation. Cancer Cell, 2: 401-413, 2002.
27. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E. Extension of life-span by introduction of telomerase into normal human cells. Science (Wash. DC), 279: 349-352, 1998.
28. Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Ying, Y., Wilson, K. S., White, M. A., Wright, W. E., and Shay, J. W. Lack of cancer-associated changes in human fibroblasts after immortalization with telomerase. Nat. Genet., 21: 115-118, 1999.
29. McKee, J. A., Banik, S. S. R., Boyer, M. J., Hamad, N. M., Lawson, J. H., Niklason, L. E., and Counter, C. M. Human arteries engineered in vitro EMBO Rep., 4: 633-638, 2003.
30. Harley, C. B. Telomerase is not an oncogene. Oncogene, 21: 494-502, 2002.
31. Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., Popescu, N. C., and Weinberg, R. A. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl. Acad. Sci. USA, 99: 12606-12611, 2002.
32. Sharma, G. G., Gupta, A., Wang, H., Scherthan, H., Dhar, S., Gandhi, V., Iliakis, G., Shay, J. W., Young, C. S., and Pandita, T. K. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene, 22: 131-146, 2003.